The importance of implementing inpatient virtual coverage in an endocrinology practice: lessons learned thus far from the COVID-19 pandemic.

Clinical Diabetes and Endocrinology Pub Date : 2021-02-09 DOI:10.1186/s40842-021-00118-7

Marcio L Griebeler, Kevin M Pantalone, Ron Gambino, David Shewmon, Jay Morrow, Daniel Mendlovic, Vinni Makin, Marwan Hamaty, Sana Hasan, M Cecilia Lansang, Keren Zhou, Bartolome Burguera

{"title":"The importance of implementing inpatient virtual coverage in an endocrinology practice: lessons learned thus far from the COVID-19 pandemic.","authors":"Marcio L Griebeler, Kevin M Pantalone, Ron Gambino, David Shewmon, Jay Morrow, Daniel Mendlovic, Vinni Makin, Marwan Hamaty, Sana Hasan, M Cecilia Lansang, Keren Zhou, Bartolome Burguera","doi":"10.1186/s40842-021-00118-7","DOIUrl":null,"url":null,"abstract":"<p><p>The COVID-19 pandemic has rapidly changed the landscape of medical care and the healthcare system needs to quickly adapt in order to continue providing optimal medical care to hospitalized patients in an efficient, effective, and safe manner. Endocrinology diseases are commonly present in patients with COVID-19 and often are major risk factors for development of severe disease. The use of electronic consultation and telemedicine have already been well-established in the outpatient setting but yet not commonly implemented in the inpatient arena. This type of remote medical care has the potential to provide a reliable delivery of endocrine care while protecting providers and patients from spreading infection. This short review intends to provide the initial steps for the development of an inpatient telemedicine endocrine service to patients with endocrine diseases. Telehealth will become part of our daily practices and has a potential to provide a safe and efficient method of consultative service.</p>","PeriodicalId":56339,"journal":{"name":"Clinical Diabetes and Endocrinology","volume":"7 1","pages":"5"},"PeriodicalIF":0.0000,"publicationDate":"2021-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/s40842-021-00118-7","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Diabetes and Endocrinology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/s40842-021-00118-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 3

Abstract

The COVID-19 pandemic has rapidly changed the landscape of medical care and the healthcare system needs to quickly adapt in order to continue providing optimal medical care to hospitalized patients in an efficient, effective, and safe manner. Endocrinology diseases are commonly present in patients with COVID-19 and often are major risk factors for development of severe disease. The use of electronic consultation and telemedicine have already been well-established in the outpatient setting but yet not commonly implemented in the inpatient arena. This type of remote medical care has the potential to provide a reliable delivery of endocrine care while protecting providers and patients from spreading infection. This short review intends to provide the initial steps for the development of an inpatient telemedicine endocrine service to patients with endocrine diseases. Telehealth will become part of our daily practices and has a potential to provide a safe and efficient method of consultative service.

查看原文本刊更多论文

在内分泌科实践中实施住院病人虚拟覆盖的重要性:迄今为止从COVID-19大流行中吸取的教训。

2019冠状病毒病大流行迅速改变了医疗保健格局，医疗保健系统需要迅速适应，以便继续以高效、有效和安全的方式为住院患者提供最佳医疗服务。内分泌疾病常见于COVID-19患者，往往是发展为严重疾病的主要危险因素。电子会诊和远程医疗的使用已经在门诊环境中建立起来，但在住院领域尚未普遍实施。这种类型的远程医疗有可能提供可靠的内分泌护理，同时保护提供者和患者免受传播感染。这篇简短的综述旨在为内分泌疾病患者的住院远程医疗内分泌服务的发展提供初步的步骤。远程保健将成为我们日常实践的一部分，并有可能提供一种安全有效的咨询服务方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical Diabetes and Endocrinology

自引率

0.00%

发文量

审稿时长

8 weeks

期刊介绍： Clinical Diabetes and Endocrinology is an open access journal publishing within the field of diabetes and endocrine disease. The journal aims to provide a widely available resource for people working within the field of diabetes and endocrinology, in order to improve the care of people affected by these conditions. The audience includes, but is not limited to, physicians, researchers, nurses, nutritionists, pharmacists, podiatrists, psychologists, epidemiologists, exercise physiologists and health care researchers. Research articles include patient-based research (clinical trials, clinical studies, and others), translational research (translation of basic science to clinical practice, translation of clinical practice to policy and others), as well as epidemiology and health care research. Clinical articles include case reports, case seminars, consensus statements, clinical practice guidelines and evidence-based medicine. Only articles considered to contribute new knowledge to the field will be considered for publication.